Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marteau

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Gastroenterologie Clinique Et Biologique|September 6, 2001
[Celiac disease]P Marteau
Nestle Nutrition Workshop Series. Clinical & Performance Programme|August 9, 2001
Diagnostic criteria for inflammatory bowel disease in adultsP Marteau
The British Journal of Nutrition|April 26, 2001
Tolerance to low-digestible carbohydrates: symptomatology and methodsP Marteau, B Flourié
Gastroenterologie Clinique Et Biologique|August 18, 2009
[The future of gastrointestinal therapeutic endoscopy: NOTES]X Dray, P Marteau
The American Journal of Gastroenterology|January 19, 2000
Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study GroupP Marteau, C Florent
Gastroenterologie Clinique Et Biologique|January 1, 1995
[Comparative randomized open study of the efficacy and tolerance of enemas with 2 gr of 4-amino-salicylic acid (4-ASA) and 1 gr of 5-amino-salicylic acid (5-ASA) in distal forms of hemorrhagic rectocolitis]P Marteau, M Halphen
Gastroenterologie Clinique Et Biologique|January 15, 2002
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]P Marteau, P Seksik
Revue De L'Infirmiere|September 1, 1990
[Non-surgical treatment of biliary lithiasis]S Zidi, P Marteau
Gastroenterology|January 6, 2005
Mesalamine in the treatment of active Crohn's diseaseAxel Dignass, P Marteau
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Side effects of 5-aminosalicylic acid]P Marteau, C Cellier
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Gastroenterologie Clinique Et Biologique|September 6, 2001
[Celiac disease]P Marteau
Nestle Nutrition Workshop Series. Clinical & Performance Programme|August 9, 2001
Diagnostic criteria for inflammatory bowel disease in adultsP Marteau
The British Journal of Nutrition|April 26, 2001
Tolerance to low-digestible carbohydrates: symptomatology and methodsP Marteau, B Flourié
Gastroenterologie Clinique Et Biologique|August 18, 2009
[The future of gastrointestinal therapeutic endoscopy: NOTES]X Dray, P Marteau
The American Journal of Gastroenterology|January 19, 2000
Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study GroupP Marteau, C Florent
Gastroenterologie Clinique Et Biologique|January 1, 1995
[Comparative randomized open study of the efficacy and tolerance of enemas with 2 gr of 4-amino-salicylic acid (4-ASA) and 1 gr of 5-amino-salicylic acid (5-ASA) in distal forms of hemorrhagic rectocolitis]P Marteau, M Halphen
Gastroenterologie Clinique Et Biologique|January 15, 2002
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]P Marteau, P Seksik
Revue De L'Infirmiere|September 1, 1990
[Non-surgical treatment of biliary lithiasis]S Zidi, P Marteau
Gastroenterology|January 6, 2005
Mesalamine in the treatment of active Crohn's diseaseAxel Dignass, P Marteau
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Side effects of 5-aminosalicylic acid]P Marteau, C Cellier
Pageof 18